Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not known to directly reduce libido as a pharmacological side effect — it is not listed in the medicine's official side-effect profile. What many people notice is a more complicated picture: weight loss, hormonal shifts, fatigue during dose increases, and improved self-confidence can all pull in different directions. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is suitable for you before any treatment begins. The NHS patient information for tirzepatide does not include reduced libido in the list of recognised side effects, which is a useful starting point for understanding what the evidence does and does not support.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a drug becomes widely discussed online, anecdotal threads quickly outpace the clinical record. The claim that Mounjaro kills libido is one of those. Tirzepatide's mechanism (activating GIP and GLP-1 receptors to reduce appetite and slow gastric emptying) has no established pathway that directly suppresses sexual function. The medicine's Summary of Product Characteristics, held on the Electronic Medicines Compendium, lists the recognised side effects in detail; decreased sex drive is not among them.
That does not mean every person's experience is identical. Side effects like nausea, fatigue and changes in appetite are real and common, particularly in the first few weeks or after a dose step-up. Feeling unwell or exhausted is not a great backdrop for intimacy. If someone tracks that dip back to the fortnight after their 5mg or 7.5mg increase, the connection is almost certainly the body adjusting to a new dose rather than any hormonal interference from the drug itself. The adjustment typically settles. Our full Mounjaro overview covers what to expect during titration in more detail.
The practical point: if you want a thorough look at how Mounjaro relates to libido, including the full breakdown of what the evidence does and does not show, we have covered that in detail. If reduced sex drive arrives alongside nausea or fatigue and improves as those settle, the cause is most likely the general side-effect burden of treatment, not a specific effect on libido pathways.
Here the picture becomes genuinely nuanced, and this is where most of the real biology sits. Fat tissue is hormonally active. It converts androgens into oestrogens via the aromatase enzyme, so significant weight loss changes the hormonal balance, usually meaningfully, and not always predictably.
In men carrying excess weight, high aromatase activity in fat cells often depresses free testosterone. As weight falls with tirzepatide, testosterone levels can rise, many men describe improved energy and libido over time. In women the picture is less linear: falling oestrogen from reduced fat mass can sometimes lower sex drive, though it is rarely the dominant effect when overall health is improving. Body fat loss also tends to reduce SHBG (sex hormone-binding globulin), freeing up more active hormone, which is usually a positive. People using hormonal contraception or HRT may notice additional interactions, our page on how Mounjaro interacts with HRT covers the absorption question specifically.
There is also the mental-health dimension. Obesity carries a well-documented burden on self-image and sexual confidence. Research consistently links higher BMI with lower sexual satisfaction scores, and that relationship appears to reverse as weight falls. A large body of evidence suggests the more common trajectory on effective treatment is improved, not reduced, libido over months of treatment.
Female libido is shaped by a wider set of factors than male libido, including menstrual cycle phase, relationship context, mental health and (critically) hormonal contraception. Mounjaro slows gastric emptying, which can transiently affect the absorption of oral medicines, including the combined pill. For the first four weeks of treatment and for four weeks after each dose increase, the NHS advises adding a barrier method alongside oral contraceptives, not because libido is at risk, but because contraceptive efficacy may be.
Separately, some women notice changes to their cycle while losing weight, which can in turn affect how they feel month to month. Our page on whether Mounjaro affects your period covers the cycle-change evidence, and there is a dedicated look at how Mounjaro affects libido in women for anyone wanting the full picture. The oral contraceptive interaction question has its own page too, see Mounjaro and the pill for the specific advice.
One thing our prescribers hear regularly: women who have struggled with polycystic ovary syndrome (PCOS) and associated low libido find their symptoms improve as weight falls and insulin resistance decreases. That is plausible biology, though it is individual and not a guarantee of any outcome.
Changes worth mentioning to your prescriber include: a persistent drop in sex drive that does not ease as GI side effects settle, changes arriving alongside mood shifts or significant fatigue that lasts beyond the early weeks, or any concern about your hormone levels. Mood changes are worth flagging promptly; any thoughts of self-harm require urgent help. You can report unexpected side effects directly at the MHRA's Yellow Card scheme.
A note on timing: if you are several months into treatment and weight has been falling steadily, your hormone profile is genuinely shifting. A GP check of testosterone or oestrogen levels at that point is reasonable and practical, the kind of thing worth raising at a routine review rather than worrying about in isolation.
For anyone thinking about treatment and wondering what all of this means for them, the most straightforward next step is a conversation with a prescriber rather than reading more forum threads. If you are already on treatment through another provider and have questions about your experience, you can explore what support looks like on our about us page. Those considering starting treatment can find information on available options and check their eligibility without any obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.